Surgical resection and chemoradiotherapy for metachronous @entity358 of XXXX .

@entity1 @entity5 @entity957 @entity900 @entity358 @entity3 @entity1487
INTRODUCTION: @entity957 of the oesophagus (BSCCE) is a relatively rare variant of oesophageal malignancy. There are no established treatment strategies for pulmonary metastases of BSCCE. PRESENTATION OF CASE: A 72-year-old @entity1 underwent oesophagectomy and subsequently received a pathological diagnosis of stage IIIA (T3N1M0) BSCCE according to Union for International @entity5 Control. One year and 5 months later, he underwent partial resection of the right lung because of @entity3 of the BSCCE. One year and 6 months after the pulmonary resection, recurrence in the right lung was observed. The @entity1 was treated with concurrent chemoradiotherapy using @entity900 and @entity1487 , and the lesion completely disappeared. The @entity1 is doing well without recurrence 5 years after chemoradiotherapy. DISCUSSION: In our case, the recurrent lesion in the right lung was observed after the pulmonary resection. It is difficult to determine whether the recurrent lesion is solitary or multiple and whether it is a local or @entity3 . Therefore, surgical indication must be decided carefully. Systemic chemotherapy or radiotherapy is useful to treat BSCCE @entity3 , however, appropriate, but which agents and their regimens are appropriate is not clear. Concurrent chemotherapy using @entity900 and @entity1487 and radiotherapy for pulmonary BSCCE metastases may provide curative therapy and should be considered. CONCLUSION: This report describes a case of recurrent @entity358 after pulmonary resection of BSCCE @entity3 , successfully treated by concurrent chemotherapy and radiotherapy. Further studies are required to establish the indications and efficacy of these therapeutic approaches.
